Research using one of the largest genomic datasets in the UK
We partner with world’s leading researchers from two critical areas: academia and the life sciences sector. Their research covers a wide scope, from translating genomic and health data into scientific breakthroughs to turning pioneering research into the medicines, treatments, and diagnostics that better patients' lives.
Access data via our secure, cloud-based AWS platform
All analysis on genomic data is done through our secure, AWS cloud-based Research Environment with patient consent and data protection at top of mind.
What you'll be able to access
Data within the Research Environment currently contains the following types of de-identified information:
De-identified genomic sequences, variants, and genes from over 100,000 genomes so you can compare mass amounts of data to support your research. You can see the details of our latest data releases here.
Imminently you'll also have access to the de-identified genomic data from over 14,700 COVID-19 study participants.
|Genomes||42,922 Cancer Genomes||75,526 Rare disease Genomes||118,448|
Genomic data on its own can't tell you much without robust patient health data. Our Research Environment collates this information so you can look at the whole picture of what might be causing disease. We're constantly adding more patients and data-depth, such as proteomic and transcriptomic data and digital histopathology.
Hospital episode statistics
Mental health services data set
Clinical actionability of prioritised variants
Mortality data ONS
A proportion of samples from our rare disease and cancer patients are routinely biobanked, and can be analysed alongside whole genome sequencing data to better understand the overarching picture of disease.
Samples available include stabilised blood for a variety of omics applications.
View summary data on the Public Data Browser
To see an overview of the data held within our Research Environment, you can use our Public Data Browser.
NHS Genomic Medicine Service (GMS) Research Collaborative
The NHS Genomic Medicine Service (GMS) Research Collaborative is a partnership between the NHS GMS, Genomics England and the National Institute of Health Research (NIHR) to support genomic research and development on a national scale.
Our Research Vision
Online text format of the Research Vision coming soon, or download the PDF below.